These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 20955167)
1. Effects of vector fusion peptides on the conformation and immune reactivity of epitope-shuffled, recombinant multi-epitope antigens. Wang J; Lin Y; Cai P; Wang H Protein Pept Lett; 2011 Jan; 18(1):73-83. PubMed ID: 20955167 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134 [TBL] [Abstract][Full Text] [Related]
3. Characterization of fine specificity of the immune response to a Plasmodium falciparum rhoptry neck protein, PfAARP. Kalra A; Mukherjee P; Chauhan VS Malar J; 2016 Sep; 15(1):457. PubMed ID: 27604988 [TBL] [Abstract][Full Text] [Related]
4. Assessment of a vaccinia virus vectored multi-epitope live vaccine candidate for Plasmodium falciparum. Dong W; Li M; Bi H; Li Y; Wu J; Qu L Int J Parasitol; 2001 Jan; 31(1):57-62. PubMed ID: 11165271 [TBL] [Abstract][Full Text] [Related]
5. A recombinant multi-epitope, multi-stage malaria vaccine candidate expressed in Escherichia coli. Li M; Bi H; Dong W; Xu W; Li Q; Li Y Chin Med J (Engl); 1999 Aug; 112(8):691-7. PubMed ID: 11601273 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Lalitha PV; Biswas S; Pillai CR; Saxena RK Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786 [TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663 [TBL] [Abstract][Full Text] [Related]
8. Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite. Mistarz UH; Singh SK; Nguyen TTTN; Roeffen W; Yang F; Lissau C; Madsen SM; Vrang A; Tiendrebeogo RW; Kana IH; Sauerwein RW; Theisen M; Rand KD Pharm Res; 2017 Sep; 34(9):1970-1983. PubMed ID: 28646324 [TBL] [Abstract][Full Text] [Related]
9. Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35. Kalra A; Edula JR; Gupta PK; Pandey AK; Chauhan VS PLoS One; 2016; 11(10):e0165720. PubMed ID: 27798691 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum. Teo WH; Nurul AA; Norazmi MN Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846 [TBL] [Abstract][Full Text] [Related]
12. Effects of the configuration of a multi-epitope chimeric malaria DNA vaccine on its antigenicity to mice. Jiang Y; Lin C; Yin B; He X; Mao Y; Dong M; Xu P; Zhang L; Liu B; Wang H Chin Med J (Engl); 1999 Aug; 112(8):686-90. PubMed ID: 11601272 [TBL] [Abstract][Full Text] [Related]
13. Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum. Wang L; Black CG; Marshall VM; Coppel RL Infect Immun; 1999 May; 67(5):2193-200. PubMed ID: 10225874 [TBL] [Abstract][Full Text] [Related]
14. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214 [TBL] [Abstract][Full Text] [Related]
15. Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL. Ruiz-Pérez F; León-Kempis R; Santiago-Machuca A; Ortega-Pierres G; Barry E; Levine M; González-Bonilla C Infect Immun; 2002 Jul; 70(7):3611-20. PubMed ID: 12065502 [TBL] [Abstract][Full Text] [Related]
16. Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol. Haddad D; Liljeqvist S; Ståhl S; Hansson M; Perlmann P; Ahlborg N; Berzins K Scand J Immunol; 1999 May; 49(5):506-14. PubMed ID: 10320644 [TBL] [Abstract][Full Text] [Related]
17. Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate. Shi YP; Das P; Holloway B; Udhayakumar V; Tongren JE; Candal F; Biswas S; Ahmad R; Hasnain SE; Lal AA Vaccine; 2000 Jun; 18(25):2902-14. PubMed ID: 10812234 [TBL] [Abstract][Full Text] [Related]